Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
US
backs vaccines for drug, nicotine addiction 4:39 PM 10/20/2009
Reuters
Earlier this month the National Institute on Drug Abuse awarded Nabi
Biopharmaceuticals a $10 million grant for a late-stage clinical trial of Nabi's NicVAX vaccine for nicotine
addiction.
...
Scientists
glean lessons from stalled AIDS vaccine 2:45 PM 10/20/2009
Reuters
Merck and Co's failed AIDS vaccine probably did not raise the risk of
infection as thought from earlier findings.
...
Swine
Flu Deaths in US Mostly in Those Under 65, CDC Reports 1:55 PM 10/20/2009
Bloomberg
Almost 90 percent of 292 deaths related to swine flu in the US
since Sept 1 were in people younger than age 65. The majority of deaths are usually found among people older
than 80.
...
Simcere
signs deal with OSI Pharmaceuticals 10:56 PM 10/20/2009
Forbes
Chinese drug developer Simcere Pharmaceutical Group signed a deal with OSI
Pharmaceuticals Inc to develop, manufacture, and market OSI's KDR/Kit inhibitor OSI-930 in China.
...
Human
Genome reports additional lupus drug data 4:28 AM 10/20/2009
Reuters
Human Genome Sciences Inc reported that experimental
lupus drug Benlysta reduced the risk of disease flare-ups by 24
percent and of severe flares by 43 percent.
...
FDA
approves GlaxoSmithKline renal cancer drug 6:18 PM 10/19/2009
MarketWatch
GlaxoSmithKline said that the US FDA has approved the use of its
Votrient medication to treat patients with advanced renal cell carcinoma.
...
Rexahn
reports good results in clinical trials 12:36 PM 10/19/2009
Bizjournals.com
Rexahn Pharmaceuticals Inc received positive results from its second phase of
clinical trials of an anti-depressive drug Serdaxin.
...
Human Genome to seek
hepatitis drug approval in Q4 8:09 AM 10/19/2009
Reuters
Human Genome Sciences Inc and partner Novartis will seek approval for their
experimental hepatitis C drug Zalbin (albinterferon-alfa 2b) in the fourth quarter. Brand name Joulferon in the
rest of the world.
...
US
rejects wider use of Roche arthritis drug 5:55 AM 10/19/2009
Forbes
The US FDA rejected use of Roche's drug Rituxan as a first line treatment
against rheumatoid arthritis (RA) citing a risk of the often fatal brain disease progressive multifocal
leukeoencephalopathy (PML).
...
US seeks more information on
Novartis lung drug 4:25 AM 10/19/2009P
Reuters
The US FDA asked for more information on dosing proposed for Novartis AG's QAB149 drug
for chronic obstructive pulmonary disease, also called "smoker's lung".
...
Cancer
drug crosses key hurdle in brain: study 2:35 PM 10/18/2009
Reuters
Angiochem Inc's experimental drug ANG1005 appears to cross a protective
barrier in the brain that screens out most chemicals. The drug reduced glioblastoma tumors and worked among
people whose cancers had metastasized to the brain.
...
Roche
drug helps halt rheumatoid arthritis progress 6:45 PM 10/17/2009
Reuters
Roche's rheumatoid arthritis drug Actemra significantly halted the
progression of joint damage in patients for two years when combined with the common treatment methotrexate.
...
Pfizer
JAK-3 arthritis drug effective in studies 6:35 PM 10/17/2009
Reuters
Experimental rheumatoid arthritis JAK inhibitor drug CP-690,550 being
developed by Pfizer Inc was found effective.
...
Medicine's
Elusive Goal: A Safe Weight-Loss Drug 5:06 AM 10/17/2009
New York Times
Obesity related illness is number one healthcare drain leaving Congress to mull
calorie tax. Less than 1 percent of the estimated $59 billion spent last year by Americans fighting fat was
spent on prescription drugs. Weight loss provided by new drugs is modest requiring diet and exercise.
...
FDA
approves Cervarix human papilloma vaccine as cervical cancer
deterrent 11:32 AM 10/16/2009
Los Angeles
Times
The US FDA approved the GlaxoSmithKline's Cervarix vaccine for use against human papilloma
virus (HPV) in females ages 10 to 25.
...
<- Day Earlier | Today's News
|
